Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SCD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM162A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A36 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA0930 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP2C9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORA16A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
EDRF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM39A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLAMF7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP8B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INSIG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMGCR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPCS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on